Stockscreener 앱 받기
3.91
1.76%
-0.07
전일 마감가:
$3.98
열려 있는:
$3.97
하루 거래량:
92,751
Relative Volume:
0.47
시가총액:
$203.10M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-2.6781
EPS:
-1.46
순현금흐름:
$-47.98M
1주 성능:
+4.83%
1개월 성능:
-24.81%
6개월 성능:
-29.80%
1년 성능:
+16.72%
1일 변동 폭
$3.90
$4.11
1주일 범위
$3.72
$4.45
52주 변동 폭
$2.58
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.91 | 203.10M | 81.06M | -55.55M | -47.98M | -1.46 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Millrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St
Hedge Fund and Insider Trading News: Ken Griffin, Bridgewater Associates, AQR Capital Management, Brookfield Asset Management, Sight Sciences Inc (SGHT), Royal Caribbean Cruises Ltd (RCL), and More - Insider Monkey
Sight sciences EVP Manohar Raheja acquires $7,400 in stock By Investing.com - Investing.com Nigeria
Sight sciences EVP Manohar Raheja acquires $7,400 in stock - Investing.com
Sight Sciences director Encrantz sells $2.06 million in stock - Investing.com India
SGHTSight Sciences, Inc. Latest Stock News & Market Updates - StockTitan
Top 3 Health Care Stocks You'll Regret Missing In November - MSN
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Sight Sciences to Present at Piper Sandler Healthcare Conference in December | SGHT Stock News - StockTitan
Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat
Sight Sciences Announces New Leadership Appointments - Vision Monday
Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates - MSN
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $5.00 at Morgan Stanley - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q3 2024 Earnings Call Transcript - Insider Monkey
Sight Sciences Reports Third Quarter Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - Vision Monday
South Africa Dry Eye Treatment Devices Market Size & Outlook, 2030 - Grand View Research
Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Sight Sciences stock price target cut on Q3 revenue headwinds - Investing.com
Sight Sciences (NASDAQ:SGHT) Receives "Neutral" Rating from Piper Sandler - MarketBeat
Sight Sciences' (SGHT) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Sight Sciences stock price target cut on Q3 revenue headwinds By Investing.com - Investing.com UK
Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler - StreetInsider.com
Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c - StreetInsider.com
Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Sight Sciences Reports Modest Growth and Optimistic Outlook - TipRanks
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Sight Sciences Appoints MK Raheja as Executive Vice - GlobeNewswire
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Sight Sciences Reports Revenue Growth and Leadership Change - TipRanks
Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Canada
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Rating Lowered to "Hold" at Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):